Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice-Reference-Cited by-同舟云学术

Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice

Published:2009-08-10 Issue:9 Volume:39 Page:2403-2411
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Chou Feng-Cheng,Shieh Shing-Jia,Sytwu Huey-Kang

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.200839177/fullpdf

Reference37 articles.

1. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins;Mosmann;J. Immunol.,1986

2. The expanding universe of T-cell subsets: Th1, Th2 and more;Mosmann;Immunol. Today,1996

3. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice;Wicker;Diabetes,1986

4. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+and CD8+T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors;Christianson;Diabetes,1993

5. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice;Rabinovitch;J. Immunol.,1995

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes;Diabetes;2024-05-21

2. A Novel Biomarker of Acute-on-Chronic Liver Failure: Galectin-9;2024-04-30

3. The glucose transporter 2 regulates CD8+ T cell function via environment sensing;Nature Metabolism;2023-10-26

4. A study of the association between Galectin-9 gene (LGALS9) polymorphisms and rheumatoid arthritis in Egyptian patients;Egyptian Rheumatology and Rehabilitation;2023-07-10

5. Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes;Frontiers in Endocrinology;2023-01-10